The phenomenon of light emission by living organisms, bioluminescence, is quite common, especially in marine species. It is known that light is generated by chemical reactions in which oxygen molecules play an important part. In the animal world, these chemical reactions take place in special luminescent cells called photocytes. These are aggregated into complex light organs, in which the intensity of light is regulated by nerve impulses, and in which light can be modulated with the help of reflectors, lenses and filters. By these means, organisms can adjust the wavelength, diffusion and intensity of light according to need. But the exact mechanisms behind these processes remain shrouded in mystery.
Jenny Krönström, a researcher at the Department of Zoology of the University of Gothenburg has put another piece of the jigsaw puzzle in place by investigating the light organs of marine jellyfish, crustaceans and fish. In her thesis she reveals that krill, the luminescent crustacean, is equipped with special muscles that regulate light intensity through contraction and relaxation.
"Light-switch" muscles of the luminescent krill. Credit: Jenny Kronstrom
Nitric oxide is also thought to play an important role in the bioluminescence of krill. It is produced in the small capillary vessels that keep the krill's photocytes supplied with oxygen, as well as in special closure muscles, sphincters, that are located at the point where these capillaries distribute blood to the photocytes. Experiments with agents that make the sphincters contract or relax show that when the sphincters relax, the krill begins to luminesce, presumably because of the increased flow of oxygenated blood to the photocytes.
As bioluminescence has developed independently at several different points in evolution, different species have developed different methods of regulating and emitting light. Jenny Krönström's research demonstrates that nitric oxide also has different effects in different species. In the remarkable deep sea Silver Hatchetfish (Argyropelecus olfersii) nitric oxide inhibits the light reaction, whilst in the Plain Midshipman fish (Porichthys notatus) it has an opposite, stimulating effect.
Biological light is not only useful to the organism itself as a biological torch, camouflage or as a means of communication; the substances that are involved in the chemical luminescent reaction have also shown themselves to be useful in modern molecular biology, in which the discovery of green fluorescent protein, which produces green light in jellyfish, led to the Nobel Prize in Chemistry in 2008.
The thesis "Control of bioluminescence: Operating the light switch in photophores from marine animals" was publicly defended on February 20th 2009.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- A Brain Circuit To Push Past Nutritional Stress
- Kudos To "The Independent" Newspaper For Debunking Nibiru "Blood Moon" Hoax
- Your Microbiome Did Not Cause Your Weight Problem
- It's Not The Nicotine: US Teens More Likely To Vape For Flavorings
- Stem Cell Therapy Heals Injured Mouse Brain
- Unhealthy Diet During Pregnancy Could Be Linked To ADHD
- Bubble-wrapped Sponge Creates Steam Using Sunlight
- "Kent - thanks, glad to have helped :)...."
- "Robert- Thank you for your patience and insight on this matter. I had just heard about this apocalyptic..."
- "Michael (reader who just commented) - I hid your comment as spam for trolling. I have a no trolling..."
- "Hi Robert. Thank you for responding to my comment and the information you kindly provided. I consider..."
- "Yes, it's just totally silly and no-one with a decent background in astronomy would give it any..."
- Breast Cancer: Genomics May Show Where Chemo Might Not Be Needed
- Gallup Poll: Great Example of How to Bias a Social Science Study
- Another Kardashian Craze Debunked
- Fad Friday: Ditch The Body Wrap!
- Commonly Cited Stat of 10 Bacteria for Every 1 Human Cell Is Wrong
- Why The EpiPen And Other Generic Drugs Are So Expensive
- Heart failure in the elderly set to triple by 2060
- Up to 80 percent of heart failure patients denied therapy to reduce hospitalization and death
- Increased risk of death for heart failure patients with each NHS hospital admission
- Nebivolol prevents anthracycline-induced cardiotoxicity
- Traffic accidents increased by 50 percent in patients with implantable cardioverter defibrillator